Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00205231
Status:
COMPLETED
Last Update Posted:
2019-03-22
First Post:
2005-09-13
Brief Title:
A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor TNF Inhibition on HIV Disease
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Study Overview
Official Title:
A Pilot Study to Examine the Feasibility and Effect on Tumor Necrosis Factor TNF Inhibition on HIV Disease
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This pilot study will investigate the safety and effect of etanercept in HIV infection by studying HIV replication and immune function as measured by CD4 counts in individuals with HIV infection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None